The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Open accessAbstract
This is a consensus statement from an international group, mostly of clinical endocrinologists. MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH or gastrin in MEN1, and calcitonin or catecholamines in MEN2. Management strategies improved after the discoveries of their genes. MEN1 has no clear syndromic variants. Tumor monitoring in MEN1 carriers includes biochemical tests yearly and imaging tests less often. Neck surgery includes subtotal or total parathyroidectomy, parathyroid cryopreservation, and thymectomy. Proton pump inhibitors or somatostatin analogs are the main management for oversecretion of entero-pancreatic hormones, except insulin. The roles for surgery of most entero-pancreatic tumors present several controversies: exclusion of most operations on gastrinomas and indications for surgery on other tumors. Each MEN1 family probably has an inactivating MEN1 germline mutation. Testing for a germline MEN1 mutation gives useful information, but rarely mandates an intervention. The most distinctive MEN2 variants are MEN2A, MEN2B, and familial medullary thyroid cancer (MTC). They vary in aggressiveness of MTC and spectrum of disturbed organs. Mortality in MEN2 is greater from MTC than from pheochromocytoma. Thyroidectomy, during childhood if possible, is the goal in all MEN2 carriers to prevent or cure MTC. Each MEN2 index case probably has an activating germline RET mutation. RET testing has replaced calcitonin testing to diagnose the MEN2 carrier state. The specific RET codon mutation correlates with the MEN2 syndromic variant, the age of onset of MTC, and the aggressiveness of MTC; consequently, that mutation should guide major management decisions, such as whether and when to perform thyroidectomy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Positional Cloning of the Gene for Multiple Endocrine Neoplasia-Type 1
Chandrasekharappa, S. C., Guru, S. C., Manickam, P., Olufemi, S.-E., Collins, F. S., Emmert-Buck, M. R., Debelenko, L. V., Zhuang, Z., Lubensky, I. A., Liotta, L. A., et al. (1997) · Science · doi:10.1126/science.276.5311.404 · Cited by 2,082
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
Mulligan, L. M., Eng, C., Healey, C. S., Clayton, D., Kwok, J. B. J., Gardner, E., Ponder, M. A., Frilling, A., Jackson, C. E., Lehnert, H., et al. (1994) · Nature Genetics · doi:10.1038/ng0194-70 · Cited by 652
Menin Interacts with the AP1 Transcription Factor JunD and Represses JunD-Activated Transcription
Agarwal, S. K., Guru, S. C., Heppner, C., Erdos, M. R., Collins, R. M., Park, S. Y., Saggar, S., Chandrasekharappa, S. C., Collins, F. S., Spiegel, A. M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80967-8 · Cited by 627
Lemmens, I. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1177 · Cited by 611
Modigliani, E., Cohen, R., Campos, J., Conte‐Devolx, B., Maes, B., Boneu, A., Schlumberger, M., Bigorgne, J., Dumontier, P., Leclerc, L., et al. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00392.x · Cited by 570
Surgery to Cure the Zollinger–Ellison Syndrome
Norton, J. A., Fraker, D. L., Alexander, H. R., Venzon, D. J., Doppman, J. L., Serrano, J., Goebel, S. U., Peghini, P. L., Roy, P. K., Gibril, F., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410902 · Cited by 504
Agarwal, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.7.1169 · Cited by 477
Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
Trump, D., Farren, B., Wooding, C., Pang, J. T., Besser, G. M., Buchanan, K. D., Edwards, C. R., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · doi:10.1093/qjmed/89.9.653 · Cited by 471
Characterization of Mutations in Patients with Multiple Endocrine Neoplasia Type 1
Bassett, J. H. D., Forbes, S. A., Pannett, A. A. J., Lloyd, S. E., Christie, P. T., Wooding, C., Harding, B., Besser, G. M., Edwards, C. R., Monson, J. P., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301729 · Cited by 444
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Somatic mutation of the MEN1 gene in parathyroid tumours
Heppner, C., Kester, M. B., Agarwal, S. K., Debelenko, L. V., Emmert-Buck, M. R., Guru, S. C., Manickam, P., Olufemi, S.-E., Skarulis, M. C., Doppman, J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-375 · Cited by 415
Pipeleers-Marichal, M., Somers, G., Willems, G., Foulis, A., Imrie, C., Bishop, A. E., Polak, J. M., Häcki, W. H., Stamm, B., Heitz, P. U., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003153221103 · Cited by 396
Multiple Endocrine Neoplasia Type 1: Clinical and Genetic Topics
Marx, S., Spiegel, A. M., Skarulis, M. C., Doppman, J. L., Collins, F. S., & Liotta, L. A. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00011 · Cited by 368
Ethical Issues With Genetic Testing in Pediatrics
Committee on Bioethics (2001) · Pediatrics · doi:10.1542/peds.107.6.1451 · Cited by 364
Multiple endocrine neoplasia type 1.
Pannett, A. A., & Thakker, R. V. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060449 · Cited by 345
Yu, F., Venzon, D. J., Serrano, J., Goebel, S. U., Doppman, J. L., Gibril, F., & Jensen, R. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.615 · Cited by 341
Multiple Facial Angiofibromas and Collagenomas in Patients With Multiple Endocrine Neoplasia Type 1
Darling, T. N. (1997) · Archives of Dermatology · doi:10.1001/archderm.1997.03890430067009 · Cited by 317
BRIERLEY, J., TSANG, R., SIMPSON, W. J., GOSPODAROWICZ, M., SUTCLIFFE, S., & PANZARELLA, T. (1996) · Thyroid · doi:10.1089/thy.1996.6.305 · Cited by 278
Cohen, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.919 · Cited by 274
Niccoli, P. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.338 · Cited by 262
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases
Siperstein, A. E., Rogers, S. J., Hansen, P. D., & Gitomirsky, A. (1997) · Surgery · doi:10.1016/s0039-6060(97)90221-x · Cited by 260
&NA; (1998) · The Endocrinologist · doi:10.1097/00019616-199803000-00017 · Cited by 254
Lethality of Multiple Endocrine Neoplasia Type I
Doherty, G. M., Olson, J. A., Frisella, M. M., Lairmore, T. C., Wells, S. A., & Norton, J. A. (1998) · World Journal of Surgery · doi:10.1007/s002689900438 · Cited by 252
Eisenhofer, G., Keiser, H., Friberg, P., Mezey, E., Huynh, T.-T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A., & Lenders, J. W. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4870 · Cited by 242
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1
Skogseid, B. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.76 · Cited by 234
Multiple Endocrine Neoplasia Type 1: A 10-Year Prospective Screening Study in Four Kindreds*
SKOGSEID, B., ERIKSSON, B., LUNDQVIST, G., LÖRELIUS, L.-E., RASTAD, J., WIDE, L., ÅKERSTRÖM, G., & ÖBERG, K. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-281 · Cited by 232
Berndt, I., Reuter, M., Saller, B., Frank-Raue, K., Groth, P., Grußendorf, M., Raue, F., Ritter, M. M., & Höppner, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4619 · Cited by 229
Carling, T., Szabo, E., Bai, M., Ridefelt, P., Westin, G., Gustavsson, P., Trivedi, S., Hellman, P., Brown, E. M., Dahl, N., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.5.2042 · Cited by 224
Management of Pheochromocytomas in Patients with Multiple Endocrine Neoplasia Type 2 Syndromes
Lairmore, T. C., Ball, D. W., Baylin, S. B., & Wells, S. A. (1993) · Annals of Surgery · doi:10.1097/00000658-199306000-00001 · Cited by 218
The Extracellular Calcium-Sensing Receptor: Its Role in Health and Disease
Brown, M., Pollak, M., & Hebert, M. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.15 · Cited by 218
Dottorini, M. E., Assi, A., Sironi, M., Sangalli, G., Spreafico, G., & Colombo, L. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960415)77:8<1556::aid-cncr20>3.0.co;2-y · Cited by 211
Management of the Zollinger–Ellison syndrome in patients with multiple endocrine neoplasia type 1
Jensen (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00281.x · Cited by 200
Is laparoscopic adrenalectomy indicated for pheochromocytomas?
Gagner, M., Breton, G., Pharand, D., & Pomp, A. (1996) · Surgery · doi:10.1016/s0039-6060(96)80058-4 · Cited by 195
Routine Measurement of Plasma Calcitonin in Nodular Thyroid Diseases
Vierhapper, H. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.5.1589 · Cited by 192
Papotti, M., Micca, F. B., Favero, A., Palestini, N., & Bussolati, G. (1993) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199303000-00010 · Cited by 185
Familial Multiple Endocrine Neoplasia Type I: A New Look at Pathophysiology
BRANDI, M. L., MARX, S. J., AURBACH, G. D., & FITZPATRICK, L. A. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-4-391 · Cited by 185
Self-citationCortical-sparing adrenalectomy for patients with bilateral pheochromocytoma
Lee, J. E., Curley, S. A., Gagel, R. F., Evans, D. B., & Hickey, R. C. (1996) · Surgery · doi:10.1016/s0039-6060(96)80056-0 · Cited by 184
The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1
Carty, S. E., Helm, A. K., Amico, J. A., Clarke, M. R., Foley, T. P., Watson, C. G., & Mulvihill, J. J. (1998) · Surgery · doi:10.1067/msy.1998.93107 · Cited by 182
Eng, C., Mulligan, L. M., Smith, D. P., Healey, C. S., Frilling, A., Raue, F., Neumann, H. P. H., Ponder, M. A., & Ponder, B. A. J. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01903.x · Cited by 173
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
Modigliani, E., VASEN, H. M., RAUE, K., DRALLE, H., FRILLING, A., GHERI, R. G., BRANDI, M. L., LIMBERT, E., NIEDERLE, B., FORGAS, L., et al. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01211.x · Cited by 172
Self-citationCadiot, G., Vuagnat, A., Doukhan, I., Murat, A., Bonnaud, G., Delemer, B., Thiéfin, G., Beckers, A., Veyrac, M., Proye, C., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70124-1 · Cited by 169
(GETC), A. T. G. D. D. T. A. C., Schlumberger, M., Abdelmoumene, N., Delisle, M., & Couette, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.73 · Cited by 167
Teh, B. T., Kytölä, S., Farnebo, F., Bergman, L., Wong, F. K., Weber, G., Hayward, N., Larsson, C., Skogseid, B., Beckers, A., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5059 · Cited by 160
Self-citationSurgical Strategy for the Treatment of Medullary Thyroid Carcinoma
Fleming, J. B., Lee, J. E., Bouvet, M., Schultz, P. N., Sherman, S. I., Sellin, R. V., Friend, K. E., Burgess, M. A., Cote, G. J., Gagel, R. F., et al. (1999) · Annals of Surgery · doi:10.1097/00000658-199911000-00013 · Cited by 152
Wiedenmann, B., Jensen, R. T., Mignon, M., Modlin, C. I., Skogseid, B. M., Doherty, G. M., & Öberg, K. (1998) · World Journal of Surgery · doi:10.1007/s002689900387 · Cited by 148
Bartsch, D. K., Langer, P., Wild, A., Schilling, T., Çeli̇k, İ., Rothmund, Μ., & Nies, C. (2000) · Surgery · doi:10.1067/msy.2000.109727 · Cited by 146
Frank‐Raue, K., Höppner, W., Frilling, A., Kotzerke, J., Dralle, H., Haase, R., Mann, K., Seif, F., Kirchner, R., Rendl, J., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1780 · Cited by 141
An Update of the Medical Treatment of Malignant Endocrine Pancreatic Tumors
Eriksson, B. K., & Öberg, K. (1993) · Acta Oncologica · doi:10.3109/02841869309083913 · Cited by 135
Wu, L., Averbuch, S. D., Ball, D. W., de Bustros, A., Baylin, S. B., & McGuire, W. P. (1994) · Cancer · Cited by 132
Clinicopathologic Studies of Thymic Carcinoids in Multiple Endocrine Neoplasia Type 1
Teh, B. T., McArdle, J. P., Chan, S. P., Menon, J., Hartley, L. C. J., Pullan, P. T., Ho, J. M. S., Khir, A. S. M., Wilkinson, S., Larsson, C., et al. (1997) · Medicine · doi:10.1097/00005792-199701000-00002 · Cited by 130
Multiple Endocrine Neoplasia Type 2: Clinical Features and Screening
Raue, F., Frank‐Raue, K., & Grauer, A. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30121-x · Cited by 129
Vasen, H. F. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.12.2717 · Cited by 120
Cadiot, G., Lebtahi, R., Sarda‐Mantel, L., Bonnaud, G., Marmuse, J., Vissuzaine, C., Ruszniewski, P. B., Guludec, D. L., & Mignon, M. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70052-5 · Cited by 119
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1
Thakker, R. V. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70150-x · Cited by 117
Improved Results of Cervical Reoperation for Medullary Thyroid Carcinoma
Moley, J. F., Dilley, W. G., & DeBenedetti, M. K. (1997) · Annals of Surgery · doi:10.1097/00000658-199706000-00011 · Cited by 114
Surgery for Asymptomatic Pancreatic Lesion in Multiple Endocrine Neoplasia Type I
Skogseid, B. M., Öberg, K., Eriksson, B., Juhlin, C. C., Granberg, D. O., Åkerström, G., & Rastad, J. (1996) · World Journal of Surgery · doi:10.1007/s002689900133 · Cited by 113
Expression of the MEN‐1 gene in a large kindred with multiple endocrine neoplasia type 1
Burgess, Greenaway, & Shepherd (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00275.x · Cited by 113
Advances and Controversies in the Diagnosis and Management of Medullary Thyroid Carcinoma
Heshmati, H. M., Gharib, H., van Heerden, J. A., & Sizemore, G. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00024-7 · Cited by 113
Adrenal Lesions in a Large Kindred With Multiple Endocrine Neoplasia Type 1
Burgess, J. R. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430190021006 · Cited by 110
Tanaka, C., Yoshimoto, K., Yamada, S., Nishioka, H., Ii, S., Moritani, M., Yamaoka, T., & Itakura, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4653 · Cited by 107
Lowney, J. K., Frisella, M. M., Lairmore, T. C., & Doherty, G. M. (1998) · Surgery · doi:10.1067/msy.1998.92561 · Cited by 104
Aggressive Forms of Gastric Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type I
Bordi, C., Falchetti, A., Azzoni, C., D’Adda, T., Canavese, G., GUARIGLIA, A., Santini, D., Tomassetti, P., & Brandi, M. L. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199709000-00012 · Cited by 103
Self-citationDuodenopancreatic Resections in Patients With Multiple Endocrine Neoplasia Type 1
Lairmore, T. C., Chen, V. Y., DeBenedetti, M. K., Gillanders, W. E., Norton, J. A., & Doherty, G. M. (2000) · Annals of Surgery · doi:10.1097/00000658-200006000-00016 · Cited by 103
Bodic, M.-F. L., Heymann, M., Lecomte, M., Berger, N., Berger, F., Louvel, A., Micco, C. D., Patey, M., de Mascarel, A., Burtin, F., et al. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00009 · Cited by 101
Huang, S., Koch, C. A., Vortmeyer, A. O., Pack, S., Lichtenauer, U. D., Mannan, P., Lubensky, I. A., Chrousos, G. P., Gagel, R. F., Pacák, K., et al. (2000) · PubMed · Cited by 100
Niccoli, P., Murat, A., Baudin, É., Henry, J. F., Proye, C. A. G., Bigorgne, J., Bständig, B., Modigliani, E., Morange, S., Schlumberger, M. J., et al. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410468 · Cited by 96
Beckers, A. M., Abs, R., Willems, P. J., der Auwera, B. J. R. V., Kovács, K., Reznik, M., & Stevenaert, A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1639957 · Cited by 94
Plasma Chromogranin A in Patients with Multiple Endocrine Neoplasia Type 1
Granberg, D. O., Stridsberg, M., Seensalu, R., Eriksson, B. K., Lundqvist, G., Öberg, K., & Skogseid, B. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5938 · Cited by 93
Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types
Corbetta, S., Pizzocaro, A., PERACCHI, M., Beck‐Peccoz, P., Faglia, G., & Spada, A. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.3311122.x · Cited by 90
Cost effectiveness of EUS for preoperative localization of pancreatic endocrine tumors
Bansal, R., Tierney, W., Carpenter, S. L., Thompson, N. W., & Scheiman, J. M. (1999) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(99)70440-2 · Cited by 88
Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases
Casanova, S., Rosenberg‐Bourgin, M., Farkast, D., Calmettes, C., Feingold, N., Heshmatl, H. M., Cohen, R., Conte-Devolx, B., Guillausseau, P., Houdent, C., et al. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00350.x · Cited by 85
German medullary thyroid carcinoma/multiple endocrine neoplasia registry
Raue, F. (1998) · Langenbeck s Archives of Surgery · doi:10.1007/s004230050143 · Cited by 85
Pathogenesis of ECL cell tumors in humans.
Bordi, C., D’Adda, T., Azzoni, C., & Ferraro, G. (1998) · PubMed Central · Cited by 75
Surgical management of patients with persistent or recurrent medullary thyroid cancer
Moley, DeBenedetti, Dilley, Tisell, & Wells (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00333.x · Cited by 75
Tonelli, F., Spini, S., Tommasi, M., Gabbrielli, G., Amorosi, A., Brocchi, A., & Brandi, M. L. (2000) · World Journal of Surgery · doi:10.1007/s002689910091 · Cited by 75
Self-citationGibril, F., Reynolds, J. C., Lubensky, I. A., Roy, P. K., Peghini, P. L., Doppman, J. L., & Jensen, R. T. (2000) · PubMed · Cited by 72
Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I.
van Heerden, J. A., Smith, S. L., & Miller, L. J. (1986) · PubMed · Cited by 68
Management of Pancreatic Endocrine Tumors in Patients With Multiple Endocrine Neoplasia Type 1
Thompson, N. W. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30250-3 · Cited by 61
10 Multiple endocrine neoplasia
Thakker, R. V., & Ponder, B. A. J. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80029-6 · Cited by 56
Moertel, C. G., Kvols, L. K., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910101)67:1<33::aid-cncr2820670107>3.0.co;2-e · Cited by 54
Adrenal Medullary Disease in Multiple Endocrine Neoplasia Type 2: Appropriate Management
Evans, D. B., Lee, J. E., Merrell, R. C., & Hickey, R. C. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30123-3 · Cited by 53
Donovan, D. T., Levy, M. L., Furst, E. J., Alford, B. R., Wheeler, T. M., Tschen, J. A., & Gagel, R. F. (1989) · PubMed · Cited by 49
Frank‐Raue, K., Kratt, T., Höppner, W., et al. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1350222 · Cited by 41
Multiple endocrine neoplasia type 2.
Ponder, B. A. J. (1990) · BMJ · doi:10.1136/bmj.300.6723.484 · Cited by 38
Trump, D., Farren, B., Wooding, C., Pang, J. T., BESSER, G. M., Buchanan, K. D., Edwards, C., Heath, D. A., Jackson, C. E., Jansen, S., et al. (1996) · QJM · Cited by 32
Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I.
Gaitan, D., Loosen, P. T., & Orth, D. N. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8099078 · Cited by 20
Cited by
Wells, S. A., Asa, S. L., Dralle, H., Elisei, R., Evans, D. B., Gagel, R. F., Lee, N., Machens, A., Moley, J. F., Pacini, F., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0335 · Cited by 2,444
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Self-citationMedullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
Kloos (Chair), R. T., Eng, C., Evans, D. B., Francis, G. L., Gagel, R. F., Gharib, H., Moley, J. F., Pacini, F., Ringel, M. D., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2008.0403 · Cited by 1,357
Gharib, H., Papini, E., Garber, J. R., Duick, D. S., Harrell, R. M., Hegedus, L., Paschke, R., Valcavi, R., & Vitti, P. (2016) · Endocrine Practice · doi:10.4158/ep161208.gl · Cited by 1,272
Metadata
- Authors
- Brandi, M. L.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-12-01
- Volume
- 86
- Issue
- 12
- Pages
- 5658-5671
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2146718153
- Cited by
- 2,031
- References
- 93
- FWCI
- 38.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.